Global Erectile Dysfunction Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Erectile Dysfunction Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2046160
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

Erectile Dysfunction is a disease where people are unable to retain their erection strong during physical intercourse which is also known as impotence.
The Erectile Dysfunction Drugs market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Erectile Dysfunction Drugs market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Erectile Dysfunction Drugs Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Erectile Dysfunction Drugs market are:
Teva Pharmaceutical Industries Ltd.
Ferring B.V.
GlaxoSmithKline Plc.
Zydus Cadila
Metuchen Pharmaceuticals, LLC.
Bayer AG
Eli Lilly and Company
Coloplast Corp
Boston Scientific Corporation
VIVUS Inc.
LUPIN

Most important types of Erectile Dysfunction Drugs products covered in this report are:
Sildenafil Citrate (Viagra)
Vardenafil (Levitra/Staxyn)
Tadalafil (Cialis)
Udenafil (Zydena)
Lodenafil Carbonate (Helleva)
Stendra/Spedra (Avanafil)
Mirodenafil (Mvix)
Others

Most widely used downstream fields of Erectile Dysfunction Drugs market covered in this report are:
Hospital Pharmacies
Retail Pharmacies
Online Sales

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Erectile Dysfunction Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Erectile Dysfunction Drugs
1.3 Erectile Dysfunction Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Erectile Dysfunction Drugs
1.4.2 Applications of Erectile Dysfunction Drugs
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Erectile Dysfunction Drugs Industry Trends
1.5.2 Erectile Dysfunction Drugs Drivers
1.5.3 Erectile Dysfunction Drugs Market Challenges
1.5.4 Erectile Dysfunction Drugs Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Erectile Dysfunction Drugs Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Erectile Dysfunction Drugs Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Erectile Dysfunction Drugs Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Erectile Dysfunction Drugs
2.2.1 Major Players Manufacturing Base of Erectile Dysfunction Drugs in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Erectile Dysfunction Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Erectile Dysfunction Drugs
2.3.3 Labor Cost of Erectile Dysfunction Drugs
2.4 Market Channel Analysis of Erectile Dysfunction Drugs
2.5 Major Down Stream Customers by Application

3 Global Erectile Dysfunction Drugs Market, by Type
3.1 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2018-2021)
3.2 Global Erectile Dysfunction Drugs Production and Market Share by Type (2018-2021)
3.3 Global Erectile Dysfunction Drugs Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Sildenafil Citrate (Viagra)
3.3.2 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Vardenafil (Levitra/Staxyn)
3.3.3 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Tadalafil (Cialis)
3.3.4 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Udenafil (Zydena)
3.3.5 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Lodenafil Carbonate (Helleva)
3.3.6 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Stendra/Spedra (Avanafil)
3.3.7 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Mirodenafil (Mvix)
3.3.8 Global Erectile Dysfunction Drugs Revenue and Growth Rate of Others
3.4 Global Erectile Dysfunction Drugs Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Erectile Dysfunction Drugs Market, by Application
4.1 Downstream Market Overview
4.2 Global Erectile Dysfunction Drugs Consumption and Market Share by Application (2018-2021)
4.3 Global Erectile Dysfunction Drugs Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Erectile Dysfunction Drugs Consumption and Growth Rate of Hospital Pharmacies (2018-2021)
4.3.2 Global Erectile Dysfunction Drugs Consumption and Growth Rate of Retail Pharmacies (2018-2021)
4.3.3 Global Erectile Dysfunction Drugs Consumption and Growth Rate of Online Sales (2018-2021)

5 Global Erectile Dysfunction Drugs Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Erectile Dysfunction Drugs Revenue and Market Share by Region (2018-2021)
5.2 Global Erectile Dysfunction Drugs Consumption and Market Share by Region (2018-2021)
5.3 Global Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Erectile Dysfunction Drugs Market Under COVID-19
5.4.2 North America Erectile Dysfunction Drugs SWOT Analysis
5.5 Europe Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Erectile Dysfunction Drugs Market Under COVID-19
5.5.2 Europe Erectile Dysfunction Drugs SWOT Analysis
5.6 China Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Erectile Dysfunction Drugs Market Under COVID-19
5.6.2 China Erectile Dysfunction Drugs SWOT Analysis
5.7 Japan Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Erectile Dysfunction Drugs Market Under COVID-19
5.7.2 Japan Erectile Dysfunction Drugs SWOT Analysis
5.8 Middle East and Africa Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Erectile Dysfunction Drugs Market Under COVID-19
5.8.2 Middle East and Africa Erectile Dysfunction Drugs SWOT Analysis
5.9 India Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Erectile Dysfunction Drugs Market Under COVID-19
5.9.2 India Erectile Dysfunction Drugs SWOT Analysis
5.10 South America Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Erectile Dysfunction Drugs Market Under COVID-19
5.10.2 South America Erectile Dysfunction Drugs SWOT Analysis
5.11 South Korea Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Erectile Dysfunction Drugs Market Under COVID-19
5.11.2 South Korea Erectile Dysfunction Drugs SWOT Analysis
5.12 Southeast Asia Erectile Dysfunction Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Erectile Dysfunction Drugs Market Under COVID-19
5.12.2 Southeast Asia Erectile Dysfunction Drugs SWOT Analysis

6 Global Erectile Dysfunction Drugs Production by Top Regions (2018-2021)
6.1 Global Erectile Dysfunction Drugs Production by Top Regions (2018-2021)
6.2 North America Erectile Dysfunction Drugs Production and Growth Rate
6.3 Europe Erectile Dysfunction Drugs Production and Growth Rate
6.4 China Erectile Dysfunction Drugs Production and Growth Rate
6.5 Japan Erectile Dysfunction Drugs Production and Growth Rate
6.6 India Erectile Dysfunction Drugs Production and Growth Rate

7 Global Erectile Dysfunction Drugs Consumption by Regions (2018-2021)
7.1 Global Erectile Dysfunction Drugs Consumption by Regions (2018-2021)
7.2 North America Erectile Dysfunction Drugs Consumption and Growth Rate
7.3 Europe Erectile Dysfunction Drugs Consumption and Growth Rate
7.4 China Erectile Dysfunction Drugs Consumption and Growth Rate
7.5 Japan Erectile Dysfunction Drugs Consumption and Growth Rate
7.6 Middle East & Africa Erectile Dysfunction Drugs Consumption and Growth Rate
7.7 India Erectile Dysfunction Drugs Consumption and Growth Rate
7.8 South America Erectile Dysfunction Drugs Consumption and Growth Rate
7.9 South Korea Erectile Dysfunction Drugs Consumption and Growth Rate
7.10 Southeast Asia Erectile Dysfunction Drugs Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Teva Pharmaceutical Industries Ltd. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.2.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Ferring B.V. Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.3.3 Ferring B.V. Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 GlaxoSmithKline Plc. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.4.3 GlaxoSmithKline Plc. Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Zydus Cadila Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.5.3 Zydus Cadila Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Metuchen Pharmaceuticals, LLC. Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.6.3 Metuchen Pharmaceuticals, LLC. Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Bayer AG Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.7.3 Bayer AG Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Eli Lilly and Company Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.8.3 Eli Lilly and Company Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Coloplast Corp Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.9.3 Coloplast Corp Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Boston Scientific Corporation Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.10.3 Boston Scientific Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 VIVUS Inc. Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.11.3 VIVUS Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 LUPIN Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Erectile Dysfunction Drugs Product Profiles, Application and Specification
8.12.3 LUPIN Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Erectile Dysfunction Drugs Market Analysis and Forecast by Type and Application
9.1 Global Erectile Dysfunction Drugs Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Sildenafil Citrate (Viagra) Market Revenue and Volume Forecast (2021-2026)
9.1.2 Vardenafil (Levitra/Staxyn) Market Revenue and Volume Forecast (2021-2026)
9.1.3 Tadalafil (Cialis) Market Revenue and Volume Forecast (2021-2026)
9.1.4 Udenafil (Zydena) Market Revenue and Volume Forecast (2021-2026)
9.1.5 Lodenafil Carbonate (Helleva) Market Revenue and Volume Forecast (2021-2026)
9.1.6 Stendra/Spedra (Avanafil) Market Revenue and Volume Forecast (2021-2026)
9.1.7 Mirodenafil (Mvix) Market Revenue and Volume Forecast (2021-2026)
9.1.8 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Erectile Dysfunction Drugs Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital Pharmacies Market Revenue and Volume Forecast (2021-2026)
9.2.2 Retail Pharmacies Market Revenue and Volume Forecast (2021-2026)
9.2.3 Online Sales Market Revenue and Volume Forecast (2021-2026)

10 Erectile Dysfunction Drugs Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Erectile Dysfunction Drugs Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Biotechnology Industry